I. Creese

发表

Classification of dopamine receptors.

D. Sibley, I. Creese, S. Leff, 1983, Advances in biochemical psychopharmacology.

Functional Roles of Dopamine D2 and D3Autoreceptors on Nigrostriatal Neurons Analyzed by Antisense KnockdownIn Vivo

J. Tepper, I. Creese, Bao-cun Sun, 1997, The Journal of Neuroscience.

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

S. Snyder, J. Coyle, I. Creese, 1978, Nature.

Regulation of putative muscarinic cholinergic receptor subtypes in rat brain

I. Creese, G. Battaglia, A. Norman, 1986, Neurochemistry International.

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

S H Snyder, S. Snyder, I. Creese, 1976, Science.

Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state.

D. Sibley, I. Creese, L. Mahan, 1983, Molecular Pharmacology.

Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.

I. Creese, S. Leff, M. Hamblin, 1985, Molecular pharmacology.

Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.

I. Creese, S. Leff, 1985, Molecular pharmacology.

Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.

I. Creese, M. Hamblin, 1982, Molecular pharmacology.

Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.

S. Snyder, I. Creese, D. Burt, 1976, Molecular pharmacology.

Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake

I. Creese, E. Pothos, B. Hoebel, 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Systemic 3-nitropropionic acid: long-term effects on locomotor behavior

I. Creese, P. Sanberg, C. Borlongan, 1994, Brain Research.

Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency

S. Snyder, I. Creese, J. Bennett, 1976, Nature.

Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum.

I. Creese, F. Tarazi, R. Bilder, 1999, Life Science.

The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.

S. Snyder, I. Creese, D. Burt, 1975, Psychopharmacology communications.

Dopamine receptor turnover rates in rat striatum are age-dependent.

I. Creese, S. Leff, R. Gariano, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Receptor adaptations to centrally acting drugs.

D. Sibley, I. Creese, 1981, Annual review of pharmacology and toxicology.

A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood

S. Snyder, I. Creese, S. Snyder, 1977, Nature.

Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.

I. Creese, M. Hamblin, Ian Creese, 1983, Life sciences.

Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): Evidence for spare receptors

I. Creese, G. Battaglia, E. Hess, 1986, Neuroscience Letters.

The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.

I. Creese, D. Burt, S. Synder, 1975, Life sciences.

Chapter 25. Brain Neurotransmitter Receptor Binding and Neuroleptic Drugs

S. Snyder, I. Creese, 1977 .

3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus.

S. Snyder, I. Creese, S. Snyder, 1978, European journal of pharmacology.

Dopamine receptors and average clinical doses.

S. Snyder, I. Creese, D. Burt, 1976, Science.

Opiate receptor binding affected differentially by opiates and opioid peptides.

I. Creese, A. Snowman, S. Childers, 1979, European journal of pharmacology.

Effect of Chronic Nicotine Treatment and Withdrawal on Rat Striatal D1 and D2 Dopamine Receptors

I. Creese, S. Xu, R. Wyatt, 1992, The Journal of pharmacy and pharmacology.

Effects of aging and cholinergic deafferentation on putative muscarinic cholinergic receptor subtypes in rat cerebral cortex

I. Creese, L. Thal, A. Norman, 1986, Neuroscience Letters.

Behavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584.

I. Creese, 1974, European journal of pharmacology.

Forskolin Potentiates the Stimulation of Rat Striatal Adenylate Cyclase Mediated by D‐1 Dopamine Receptors, Guanine Nucleotides, and Sodium Fluoride

I. Creese, G. Battaglia, E. Hess, 1986, Journal of neurochemistry.

Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia.

I. Creese, E. Hess, 1986, Clinical neuropharmacology.

Agonist interactions with dopamine receptors: focus on radioligand-binding studies.

D. Sibley, I. Creese, S. Leff, 1984, Federation proceedings.

Dopamine receptor binding regulated by guanine nucleotides.

S. Snyder, I. Creese, T. Usdin, 1979, Molecular pharmacology.

Neurotransmitter receptor binding: regional distribution in human brain

I. Creese, D. Bylund, J. Bennett, 1977, Journal of neurochemistry.

Regulation of Agonist Interactions with Brain D-1 Dopamine Receptors

I. Creese, S. Leff, 1986 .

Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.

I. Creese, J. Eubanks, A. Norman, 1989, Journal of Pharmacology and Experimental Therapeutics.

Receptor binding and pharmacological activity of opiates in the guinea-pig intestine.

S. Snyder, I. Creese, S. Snyder, 1975, The Journal of pharmacology and experimental therapeutics.

Behavioral correlates of dopaminergic supersensitivity.

S. Iversen, I. Creese, Iversen Sd, 1975, Advances in neurology.

Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.

I. Creese, M. Riva, 1989, Molecular pharmacology.

Identification of subtypes of [3H]prazosin-labelled α1 receptor binding sites in rat brain

I. Creese, G. Battaglia, A. Morrow, 1985 .

Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides.

S. Snyder, I. Creese, S. Snyder, 1978, European journal of pharmacology.

NEW INSIGHTS INTO THE REGULATION OF DOPAMINE RECEPTOR SUBTYPES AND THEIR ROLES IN BEHAVIOR

I. Creese, 1988 .

In Vitro and In Vivo Irreversible Blockade of Cortical S2 Serotonin Receptors by N‐Ethoxycarbonyl‐2‐Ethoxy‐1,2‐Dihydroquinoline: A Technique for Investigating S2 Serotonin Receptor Recovery

I. Creese, G. Battaglia, A. Norman, 1986, Journal of neurochemistry.

Dopamine receptors re-explained

I. Creese, S. Leff, 1983 .

Antischizophrenic drugs: differential plasma protein binding and therapeutic activity.

S. Snyder, I. Creese, K. Freedberg, 1979, Life sciences.

3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and derivatives.

S. Snyder, I. Creese, A. A. Manian, 1978, European journal of pharmacology.

I. Creese, G. Battaglia, A. Norman, 1988, European journal of pharmacology.

3H-Apomorphine interactions with dopamine receptors in calf brain.

S. Snyder, I. Creese, L. Thal, 1978, European journal of pharmacology.

Radioligand binding studies: evidence for multiple dopamine receptors.

D. Sibley, I. Creese, 1979, Communications in psychopharmacology.

Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls

S. Snyder, I. Creese, H. Meltzer, 1981, Psychiatry Research.

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

S. Snyder, I. Creese, D. Burt, 1977, Science.

Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level

I. Creese, M. Riva, O. Civelli, 1990, Neuroscience Letters.

Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.

I. Creese, A. Morrow, 1986, Molecular pharmacology.

The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists.

S H Snyder, A. Feinberg, S. Snyder, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes.

S. Snyder, I. Creese, D. Burt, 1976, Molecular pharmacology.

Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.

S. Iversen, I. Creese, I Creese, 1973, Brain research.

CENTRALLY ACTING DRUGS

D. Sibley, I. Creese, 1981 .

Regulation by Cations of [3H]Spiroperidol Binding Associated with Dopamine Receptors of Rat Brain

S. Snyder, I. Creese, T. Usdin, 1980, Journal of neurochemistry.

3H-Spiroperidol labels dopamine receptors in pituitary and brain.

S. Snyder, I. Creese, R. Schneider, 1977, European journal of pharmacology.

Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.

S. Snyder, I. Creese, D. Burt, 1975, Life sciences.

Radioligand Binding Studies of Agonist Interactions with Dopamine Receptors

D. Sibley, I. Creese, S. Leff, 1984 .

Ontogenesis of dopamine receptor binding in the corpus striatum of the rat

S. Snyder, I. Creese, D. Burt, 1977, Brain Research.

Dopamine receptor subtype imbalance in schizophrenia.

J. Kleinman, I. Creese, H. Bracha, 1987, Life sciences.

Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.

I. Creese, G. Battaglia, E. Hess, 1986, European journal of pharmacology.

Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.

I. Creese, E. Hess, 1986, Advances in experimental medicine and biology.

The pharmacological and anatomical substrates of the amphetamine response in the rat

S. Iversen, I. Creese, 1975, Brain Research.

Regulation of Motor Behavior by Dopamine Receptor Subtypes

I. Creese, A. Ouagazzal, Ming Zhang, 1997 .

Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.

I. Creese, M. Hamblin, 1982, Molecular pharmacology.

3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors.

I. Creese, L. Padgett, F. Lopez, 1979, European journal of pharmacology.

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.

S. Snyder, I. Creese, D. Burt, 1977, Science.

Guanine nucleotides distinguish between two dopamine receptors

S. Snyder, I. Creese, T. Usdin, 1979, Nature.

3H-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium.

I. Creese, M. Hamblin, Ian Creese, 1982, Life sciences.

Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides.

I. Creese, S. Synder, T. Prosser, 1978, Life sciences.

Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.

I. Creese, G. Battaglia, E. Hess, 1987, Molecular pharmacology.

Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.

I. Creese, A. Norman, 1986, Molecular pharmacology.

Antisense Knockdown of Dopamine Receptors

I. Creese, S. Kaur, S. Kaur, 2000 .

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: Behavioral correlates

I. Creese, Ming Zhang, 1993, Neuroscience Letters.

Differential regulation of expression of rat hippocampal muscarinic receptor subtypes following fimbria-fornix lesion.

I. Creese, Z. Zang, 1997, Biochemical pharmacology.

Reduction in muscarinic receptors by antisense oligodeoxynucleotide.

I. Creese, W. Florijn, Z. Zang, 1994, Biochemical pharmacology.

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

S. Snyder, I. Creese, D. Burt, 1976, Science.

Regulation of ligand binding to pituitary D-2 dopaminergic receptors. Effects of divalent cations and functional group modification.

D. Sibley, I. Creese, 1983, The Journal of biological chemistry.

Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor.

D. Sibley, I. Creese, D R Sibley, 1982, The Journal of biological chemistry.

Radioligand Binding Studies of Dopamine Receptors in the Central Nervous System

D. Sibley, I. Creese, S. Leff, 1983 .

CNS Dopamine Receptors

D. Sibley, I. Creese, S. Leff, 1983 .

The classification of dopamine receptors: relationship to radioligand binding.

D. Sibley, I. Creese, S. Leff, 1983, Annual review of neuroscience.

Dopamine receptors in the central nervous system.

D. Sibley, I. Creese, S. Leff, 1982, International review of neurobiology.

Species variation in dopamine receptor binding.

S. Snyder, I. Creese, K. Stewart, 1979, European journal of pharmacology.

Modulation of alpha-1 adrenergic receptors in rat brain following chronic reserpine

I. Creese, A. Morrow, A. D. Chen, 1986, Neurochemistry International.

[3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.

I. Creese, G. Battaglia, A. Norman, 1985, Molecular pharmacology.

Discrimination by temperature of opiate agonist and antagonist receptor binding.

S. Snyder, C. Pert, G. Pasternak, 1975, Life sciences.

The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat

S. Iversen, I. Creese, 2004, Psychopharmacologia.

Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations

S. Snyder, I. Creese, D. Avery, 1979, Psychiatry Research.

Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.

D. Sibley, I. Creese, 1983, Molecular pharmacology.

Reducing Gene Expression in the Brain via Antisense Methods

J. Tepper, I. Creese, A. Ouagazzal, 1997, Current protocols in neuroscience.

Dopamine receptor binding in the corpus striatum of mammalian brain.

S. Snyder, I. Creese, S. Enna, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Butyrophenone influences on the opiate receptor.

S. Snyder, I. Creese, A. Feinberg, 1976, European journal of pharmacology.

Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment

I. Creese, F. Tarazi, W. Florijn, 1997, Neuroscience.

Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.

I. Creese, F. Tarazi, W. Florijn, 1997, The Journal of pharmacology and experimental therapeutics.

Chapter 4 Dopamine receptors

I. Creese, F. Tarazi, W. Florijn, 1997 .

Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics

I. Creese, F. Tarazi, W. Florijn, 1996, Psychopharmacology.

Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.

S. Snyder, I. Creese, S. Snyder, 1979, European journal of pharmacology.

Ascorbic acid enables reversible dopamine receptor 3H-agonist binding.

D. Sibley, I. Creese, S. Leff, 1981, Life sciences.

Neurobiology of Central D1-Dopamine Receptors

I. Creese, G. Breese, 1986, Advances in Experimental Medicine and Biology.

The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat

I. Creese, G. Koob, H. Le, 1987, Neuroscience Letters.

Classical and atypical antipsychotic drugs: new insights

I. Creese, 1983, Trends in Neurosciences.

Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.

I. Creese, M. Riva, 1989, Molecular pharmacology.

Kainate lesion dissociates striatal dopamine receptor radioligand binding sites.

I. Creese, S. Leff, L. Adams, 1981, European journal of pharmacology.

Dopamine D2-like receptors are elevated after chronic treatment with typical and atypical neuroleptics

I. Creese, F. Tarazi, W. Florijn, 1995, Schizophrenia Research.

Distinct localization and regulation of dopamine D3 receptors: Autoradiographic studies

I. Creese, F. Tarazi, W. Florijn, 1995, Schizophrenia Research.

Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors.

D. Sibley, I. Creese, S. Leff, 1982, Life sciences.

6 – Dopamine Receptors

I. Creese, 1986 .

Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms

I. Creese, G. Battaglia, A. Norman, 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Solubilization of D-2 dopamine receptors from canine caudate: agonist-occupation stabilizes guanine nucleotide sensitive receptor complexes.

I. Creese, S. Leff, Ian Creese, 1982, Biochemical and biophysical research communications.

Dopamine receptor stimulation and striatal kainic acid neurotoxicity

I. Creese, P. Sanberg, 1981, The Journal of pharmacy and pharmacology.

Dopamine receptors explained

I. Creese, 1982, Trends in Neurosciences.

Dopamine receptor binding in bovine intermediate lobe pituitary membranes.

D. Sibley, I. Creese, Ian Creese, 1980, Endocrinology.

Up-regulation of serotonergic binding sites labeled by [3H]WB4101 following fimbrial transection and 5,7-dihydroxytryptamine-induced lesions.

I. Creese, G. Battaglia, A. Morrow, 1985, Life sciences.

MULTIPLE DOPAMINE RECEPTORS

S. Snyder, I. Creese, S. Snyder, 1979 .

Amphetamine response in rat after dopamine neurone destruction.

S. Iversen, I. Creese, 1972, Nature: New biology.

Septal deafferentation increases hippocampal adrenergic receptors: correlation with sympathetic axon sprouting.

I. Creese, A. Morrow, R. Loy, 1983, Proceedings of the National Academy of Sciences of the United States of America.

CATECHOLAMINE RECEPTOR BINDING IN BRAIN

S. Snyder, I. Creese, D. U'prichard, 1979 .

NEUROLEPTIC BINDING SITES IN BRAIN

I. Creese, S. Leff, 1984 .

[3H]WB4101 labels S1 serotonin receptors in rat cerebral cortex.

I. Creese, G. Battaglia, A. Morrow, 1984, European journal of pharmacology.

Alteration of nicotinic cholinergic agonist binding sites in hippocampus after fimbria transection

I. Creese, A. Morrow, R. Loy, 1985, Brain Research.

Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors

I. Creese, Ab Norman, EJ Hess, 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Dopamine Receptors: A Classification

I. Creese, S. Leff, 1982, Journal of Clinical Psychopharmacology.

Comments on the commentary by Dr. Seeman

D. Sibley, I. Creese, 1982 .

Biochemical Actions of Neuroleptic Drugs: Focus on the Dopamine Receptor

S. Snyder, I. Creese, D. Burt, 1978 .

Stimulus-evoked changes in neostriatal dopamine levels in awake and anesthetized rats as measured by microdialysis

J. Tepper, I. Creese, D. Schwartz, 1991, Brain Research.

Expression of rat striatal D1 and D2 dopamine receptor mRNAs: Ontogenetic and pharmacological studies

D. Sibley, I. Creese, S. Xu, 1992, Neurochemistry International.

Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment.

D. Sibley, F. Monsma, I. Creese, 1992, Life sciences.

D2dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum

I. Creese, G. Battaglia, E. Hess, 1985, Neuroscience Letters.

Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.

I. Creese, A. Chen, 1985, European journal of pharmacology.

Sulpiride isomers exhibit reversed stereospecificity for D-1 and D-2 dopamine receptors in the CNS

I. Creese, S. Leff, A. Chen, 1984, Neuropharmacology.

Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.

I. Creese, S. Leff, M. Hamblin, 1984, Biochemical pharmacology.

Dopaminergic D-3 binding sites are not presynaptic autoreceptors

I. Creese, S. Leff, 1983, Nature.

Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment.

I. Creese, G. Battaglia, A. Norman, 1987, The Journal of pharmacology and experimental therapeutics.

Neuroreceptors: Basic and Clinical Aspects edited by Earl Usdin, William E. Bunney, Jr and John M. Davis, John Wiley & Sons, 1981. £21.50 (xi + 279 pages) ISBN 0 471 27876 9

I. Creese, 1982, Trends in Neurosciences.

Dopamine Receptor Subtypes: Differential Regulatory Characteristics and Levels in Schizophrenia

I. Creese, 1988 .

Intra-accumbens infusion of D3 receptor agonists reduces spontaneous and dopamine-induced locomotion

I. Creese, A. Ouagazzal, 2000, Pharmacology Biochemistry and Behavior.

Guanine nucleotides regulate anterior pituitary dopamine receptors.

D. Sibley, I. Creese, David R. Sibley, 1979, European journal of pharmacology.

Dopamine receptor binding of multiple ligands

I. Creese, D. Burt, S. H. Snyder, 1976 .

GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.

L. J. Chen, I. Creese, G. Jin, 1997, Biochemical pharmacology.

Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.

I. Creese, E. Hess, L. Albers, 1986, The Journal of pharmacology and experimental therapeutics.

Phenoxybenzamine discriminates multiple dopamine receptors.

I. Creese, M. Hamblin, 1980, European journal of pharmacology.

Pseudo non-competitive agonist interactions with dopamine receptors.

D. Sibley, I. Creese, 1980, European journal of pharmacology.

Electrophysiological Consequences of D 2 and/or D 3 Receptor Knockout by Antisense Oligonucleotides in Nigrostriatal Dopaminergic Neurons

J. Tepper, I. Creese, L. Martin, 1996 .

N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.

D. Sibley, I. Creese, S. Xu, 1991, The Journal of pharmacology and experimental therapeutics.

Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?

S. Iversen, I. Creese, 1975, Psychopharmacology bulletin.

"Selective" D-1 and D-2 receptor antagonists fail to differentially alter supersensitive locomotor behavior in the rat.

N. Swerdlow, I. Creese, G. Koob, 1986, Life sciences.

Multiple daily amphetamine administration decreases both [3H]agoinst and [3]antagonist dopamine receptor binding

D. Sibley, D. Segal, I. Creese, 1982, Experientia.

Chronic neuroleptic treatment and dopamine receptor regulation.

I. Creese, S. Snyder, 1980, Advances in biochemical psychopharmacology.